ArticleProceedings of the National Academy of Sciences of the United States of America2020

The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.

Kruttika Bhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.